Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-04-005197
Filing Date
2004-02-19
Accepted
2004-02-19 17:00:45
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a04-2538_110k.htm 10-K 1591965
3 EX-10.15 a04-2538_1ex10d15.htm EX-10.15 339613
4 EX-23.1 a04-2538_1ex23d1.htm EX-23.1 3021
5 EX-31.1 a04-2538_1ex31d1.htm EX-31.1 11795
6 EX-31.2 a04-2538_1ex31d2.htm EX-31.2 11331
7 EX-32 a04-2538_1ex32.htm EX-32 4548
  Complete submission text file 0001104659-04-005197.txt   1964335
Mailing Address 10241 WATERIDGE CIRCLE SUITE C200 SAN DIEGO CA 92121
Business Address 10241 WATERIDGE CIRCLE SUITE C200 SAN DIEGO CA 92121 8582024900
STRESSGEN BIOTECHNOLOGIES CORP (Filer) CIK: 0001064990 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 333-12570 | Film No.: 04616737
SIC: 2836 Biological Products, (No Diagnostic Substances)